Evidence map›Paper›PMID 34925508›Full record

ArticleJournal of oncology2021

Prognosis Implication of a Novel Metabolism-Related Gene Signature in Ewing Sarcoma.

Zhuo-Yuan Chen, Huiqin Yang, Jie Bu, Qiong Chen, Zhen Yang, Hui Li

Abstract read
In one paragraph

Article in Journal of oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhuo-Yuan ChenDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, 139th Renmin Middle Road, Changsha, Hunan, China.ORCID https://orcid.org/0000-0001-7554-8925
Huiqin YangDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, 139th Renmin Middle Road, Changsha, Hunan, China.
Jie BuHunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, 283 Tongzipo Road, Changsha, Hunan, China.ORCID https://orcid.org/0000-0003-0637-4954
Qiong ChenDepartment of Ultrasound, Wuhan No. 1 Hospital, 215 Zhongshan Dadao, Wuhan, Hubei, China.
Zhen YangDepartment of Radiology, Hubei Cancer Hospital, 116 Zhuodaoquan South Road, Wuhan, Hubei, China.
Hui LiDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, 139th Renmin Middle Road, Changsha, Hunan, China.ORCID https://orcid.org/0000-0003-4759-1779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ewing sarcoma (ES) is one of the most common bone cancers in adolescents and children. Growing evidence supports the view that metabolism pathways play critical roles in numerous cancers (He et al. (2020)). However, the correlation between metabolism-associated genes (MTGs) and Ewing sarcoma has not been investigated systematically. Here, based on the univariate Cox regression analysis, we get survival genes from differentially expressed genes (DEGs) from Gene Expression Omnibus (GEO) cohort. Multivariate Cox regression analysis and least absolute shrinkage and selection operator (LASSO) regression analysis were employed to establish the MTG signature. Comprehensive survival analyses including receiver operating characteristic (ROC) curves and Kaplan-Meier analysis were applied to estimate the independent prognostic value of the signature. The ICGC cohort served as the validation cohort. A nomogram was constructed based on the risk score of the MTG signature and other independent clinical variables. The CIBERSORT algorithm was applied to estimate immune infiltration. In addition, we explored the correlation between MTG signature and immune checkpoints. Collectively, this work presents a novel MTG signature for prognostic prediction of Ewing sarcoma. It also suggests six genes that are potential prognostic indicators and therapeutic targets for ES.

Identifiers

PMID34925508
PMCPMC8683175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.